BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martínez-Romero C, García-Sastre A. Against the clock towards new Ebola virus therapies. Virus Res 2015;209:4-10. [PMID: 26057711 DOI: 10.1016/j.virusres.2015.05.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Ekins S, Freundlich JS, Clark AM, Anantpadma M, Davey RA, Madrid P. Machine learning models identify molecules active against the Ebola virus in vitro. F1000Res 2015;4:1091. [PMID: 26834994 DOI: 10.12688/f1000research.7217.3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
2 Dilley KA, Voorhies AA, Luthra P, Puri V, Stockwell TB, Lorenzi H, Basler CF, Shabman RS. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing. PLoS One 2017;12:e0178717. [PMID: 28636653 DOI: 10.1371/journal.pone.0178717] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
3 Marrugal-Lorenzo JA, Serna-Gallego A, González-González L, Buñuales M, Poutou J, Pachón J, Gonzalez-Aparicio M, Hernandez-Alcoceba R, Sánchez-Céspedes J. Inhibition of adenovirus infection by mifepristone. Antiviral Res 2018;159:77-83. [PMID: 30268911 DOI: 10.1016/j.antiviral.2018.09.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
4 Cong Y, Dyall J, Hart BJ, DeWald LE, Johnson JC, Postnikova E, Zhou H, Gross R, Rojas O, Alexander I, Josleyn N, Zhang T, Michelotti J, Janosko K, Glass PJ, Flint M, McMullan LK, Spiropoulou CF, Mierzwa T, Guha R, Shinn P, Michael S, Klumpp-Thomas C, McKnight C, Thomas C, Eakin AE, O'Loughlin KG, Green CE, Catz P, Mirsalis JC, Honko AN, Olinger GG Jr, Bennett RS, Holbrook MR, Hensley LE, Jahrling PB. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus. PLoS One 2016;11:e0166318. [PMID: 27902714 DOI: 10.1371/journal.pone.0166318] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
5 Marrugal-Lorenzo JA, Serna-Gallego A, Berastegui-Cabrera J, Pachón J, Sánchez-Céspedes J. Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections. Sci Rep 2019;9:17. [PMID: 30626902 DOI: 10.1038/s41598-018-37290-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
6 Ekins S, Freundlich JS, Clark AM, Anantpadma M, Davey RA, Madrid P. Machine learning models identify molecules active against the Ebola virus in vitro. F1000Res 2015;4:1091. [PMID: 26834994 DOI: 10.12688/f1000research.7217.3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 7] [Article Influence: 5.6] [Reference Citation Analysis]
7 Ekins S, Freundlich JS, Clark AM, Anantpadma M, Davey RA, Madrid P. Machine learning models identify molecules active against the Ebola virus in vitro. F1000Res 2015;4:1091. [DOI: 10.12688/f1000research.7217.2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
8 Miller JL, Spiro SG, Dowall SD, Taylor I, Rule A, Alonzi DS, Sayce AC, Wright E, Bentley EM, Thom R, Hall G, Dwek RA, Hewson R, Zitzmann N. Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model. PLoS One 2016;11:e0167018. [PMID: 27880800 DOI: 10.1371/journal.pone.0167018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
9 Lyman M, Mpofu JJ, Soud F, Oduyebo T, Ellington S, Schlough GW, Koroma AP, McFadden J, Morof D. Maternal and perinatal outcomes in pregnant women with suspected Ebola virus disease in Sierra Leone, 2014. Int J Gynaecol Obstet 2018;142:71-7. [PMID: 29569244 DOI: 10.1002/ijgo.12490] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Ullah MA, Sarkar B, Islam SS. Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus. Immunobiology 2020;225:151949. [PMID: 32444135 DOI: 10.1016/j.imbio.2020.151949] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]